UCB BIOPHARMA
ActiveDirectors
Directors
4 directors, no change since 2024
Jean-Luc Fleurial
Current
Director · since 12-12-2017 · term without a fixed end · listed in the 2025 annual accounts, filed on 23-07-2026
Current
Current
Current
Owners and capital
Shareholders
2 ownersChain of control
- U C B
- UCB PHARMA
- UCB BIOPHARMA
Owners 2
- UCB PHARMAparentEquity €16.23bn Profit of €4.24bn in 2025 (profit of €947.4m in 2024) Checked score 94100%
-
consolidated
Owners through the years 2013 to 2025
| Name | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UCB PHARMA | 99% | 79.31% | 80.47% | 81.92% | 100% | ||||||||
| U C B | consolidates | ||||||||||||
| UCB Manufacturing IncUS | 18.08% | ||||||||||||
Source: shareholder structure in its own accounts, parent in its own accounts, lists of holdings in the owners' accounts
Capital transactions
Shareholders according to the deeds
Contribution
deed of 28-07-2022 ↗
- UCB PHARMA 16,968,535 shares · €819,225,268.29 in kind
At incorporation
deed of 30-12-2013 ↗
- UCB Pharma founder
- UCB Fipar founder
Capital over time
- 12-05-2025 Capital reduction of €72,309,112 · in a demerger
- 02-01-2025 Capital reduction of €2,501,571,025 · to €1,093,398,007 · to absorb losses
- 28-07-2022 Converted to unavailable equity · €1,231,517,238.43
- 25-05-2021 Capital stated in the deed · €563,451,793.59 · 11,670,724 shares
- 04-12-2019 Capital reduction of €827,934,814.30 · to €562,969,843.36 · to absorb losses
- 03-05-2019 Capital increase of €33,044,986.43 · to €1,383,611,620.86
- 03-05-2019 Capital increase of €7,293,036.80 · to €1,390,904,657.66
- 18-12-2018 Capital increase of €1,662,293,910 · to €3,647,358,235.46 · from reserves
Show 8 older capital entries
- 18-12-2018 Capital reduction of €2,397,392,818.98 · to €1,249,965,416.48 · to absorb losses
- 18-12-2018 Capital increase of €100,601,217.95 · to €1,350,566,634.43 · 844,119 new shares
- 15-06-2016 Capital stated in the deed · €1,985,064,325.46
- 11-04-2016 Capital increase of €110,676,279.18 · to €1,985,064,325.46 · 584,761 new shares
- 24-07-2014 Capital increase of €25,666,047.94 · to €1,486,640,157.21
- 24-07-2014 Capital increase of €387,729,289.07 · to €1,874,388,046.28
- 26-05-2014 Capital increase of €1,460,974,109.27 · to €1,460,992,709.27
- 30-12-2013 Incorporation · €18,600 · 100 shares
Mandate history
16 people, 4 in office
- Board
- Statutory auditor
- Other function
- mandate already running before its first mention
- end not dated
| Name | Functions and periods |
|---|---|
| Jean-Luc Fleurial |
|
| Sandrine DUFOUR |
|
| Denelle J. Waynick Johnson |
|
| Alistair Henry |
|
| Forvis Mazars Réviseurs d’Entreprises |
|
| Mazars Bedrijfsrevisoren - Réviseurs d'Entreprises BV/SRL |
|
| Patel, Dhavalkumar |
|
| William Silbey |
|
| PwC Réviseurs d'Entreprises SRL |
|
| THIELGEN Detlef |
|
| Anna Sessan Richo |
|
| ENDERLIN Fabrice René Marcel |
|
| Ismail Kola |
|
| Mark McDade |
|
| Jean Fossion |
|
| McDADE Mark Daniel |
|
Articles of association
- Power of attorneyA power of attorney lets someone perform specific acts on the company's behalf.
- “Ann Gudiens”“Laetitia Munoko”“Natascha Tassier”“Loïc Petit”“Blerta Aliaj”“Olivier Bruneel”“Sébastien Lair”“Anke Sanders”“Laurent Simonart”“Alexandra Nijssen”“Sylvie Rauel-Rasmussen”“Myriam Juckler”“Philip Vanstraelen”“Dennis Beyers”“Aurélie Saint-Amand”“Lydia Sauvenière”“Caroline Vancoillie”“Xavier Michel”“Valentijn Peeters”“Davina Devleeschouwer”“Dominique Lecocq”“Bram De Pooter”
Articles of association, deed of 02-10-2025 (in French)